Reverse transcriptase (RT) is a type of enzyme used to create DNA from an RNA template. It is a key enzyme used in the replication of retroviruses, such as HIV. It is also used in the laboratory for the production of cDNA from mRNA for use in molecular biology experiments.
Reverse transcriptase was first discovered by Temin and Baltimore in 1970. It is a ribonucleotide reductase enzyme that is used to generate DNA from an RNA template. RT is used in the life cycle of retroviruses to produce double-stranded DNA from single-stranded RNA, which is then integrated into the host genome. It is also used in the laboratory for the production of cDNA from mRNA for use in molecular biology experiments.
The global reverse transcriptase market is estimated to reach a value of approximately $2.22 billion by 2024. The market is expected to experience significant growth due to the increasing prevalence of infectious diseases, the growing demand for diagnosis and treatment, and the rising number of research and development activities. The rising demand for RT products in the diagnostics sector is another factor driving the market. In addition, the growing use of RT in gene-editing, stem cell research, and gene therapies is expected to boost the market.
The global Reverse Transcriptase market was valued at US$ 321.7 million in 2022 and is anticipated to reach US$ 419 million by 2029, witnessing a CAGR of 3.8% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
A detailed market research report on Global Reverse Transcriptase Market available at: https://www.themarketreports.com/report/global-reverse-transcriptase-market-research-report
This report aims to provide a comprehensive presentation of the global market for Reverse Transcriptase, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Reverse Transcriptase.
The major global companies of Reverse Transcriptase include Thermo Fisher, Promega, Roche, Bio-Rad, Takara Bio, Agilent, Qiagen, Fapon Biotech, Toyobo, Vazyme, New England Biolabs etc. In 2021, the world’s top three vendors accounted for approximately % of the revenue.
Ask for more details or sample of this report at: https://www.themarketreports.com/report/ask-your-query/1411039
The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479